Pediatric anthrax clinical management
Pediatrics, ISSN: 1098-4275, Vol: 133, Issue: 5, Page: e1411-36
2014
- 45Citations
- 69Captures
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations45
- Citation Indexes42
- 42
- CrossRef37
- Policy Citations3
- 3
- Captures69
- Readers69
- 69
Article Description
Anthrax is a zoonotic disease caused by Bacillus anthracis, which has multiple routes of infection in humans, manifesting in different initial presentations of disease. Because B anthracis has the potential to be used as a biological weapon and can rapidly progress to systemic anthrax with high mortality in those who are exposed and untreated, clinical guidance that can be quickly implemented must be in place before any intentional release of the agent. This document provides clinical guidance for the prophylaxis and treatment of neonates, infants, children, adolescents, and young adults up to the age of 21 (referred to as "children") in the event of a deliberate B anthracis release and offers guidance in areas where the unique characteristics of children dictate a different clinical recommendation from adults. Copyright © 2014 by the American Academy of Pediatrics.
Bibliographic Details
http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=84899892740&origin=inward; http://dx.doi.org/10.1542/peds.2014-0563; http://www.ncbi.nlm.nih.gov/pubmed/24777226; https://publications.aap.org/pediatrics/article/133/5/e1411/32670/Pediatric-Anthrax-Clinical-Management; https://dx.doi.org/10.1542/peds.2014-0563; http://pediatrics.aappublications.org/cgi/doi/10.1542/peds.2014-0563; http://pediatrics.aappublications.org/content/133/5/e1411; http://pediatrics.aappublications.org/content/133/5/e1411.abstract; http://pediatrics.aappublications.org/content/133/5/e1411.full.pdf; http://pediatrics.aappublications.org/lookup/doi/10.1542/peds.2014-0563; https://pediatrics.aappublications.org/content/133/5/e1411; https://pediatrics.aappublications.org/content/133/5/e1411.abstract; https://pediatrics.aappublications.org/content/pediatrics/133/5/e1411.full.pdf; http://pediatrics.aappublications.org/content/133/5/e1411.long
American Academy of Pediatrics (AAP)
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know